Companion Animal Parasiticides Market Size, Share, Growth, and Industry Analysis, By Type (Endoparasiticides, Ectoparasiticides, Endectocides), By Application (Dogs/Cats, Equine), Regional Insights and Forecast To 2032

COMPANION ANIMAL PARASITICIDES MARKETREPORT OVERVIEW

• 

   Request a Free Sample To Get More Information on this Market

global companion animal parasiticides market size was USD 2.21 billion in 2023 and market is projected to touch USD 3.23 billion by 2032 at CAGR 4.3% during the forecast period.

Companion animal parasiticides are medications or treatments used to prevent or treat parasitic infections in pets, such as dogs and cats. These parasites can include fleas, ticks, mites, lice, and worms (e.g., roundworms, hookworms, tapeworms, and heartworms). Companion animal parasiticides can be administered in various forms, including topical treatments (applied directly to the skin), oral medications (given by mouth), and injections. Preventative treatments are often administered on a regular basis to protect pets from potential infestations, while therapeutic treatments are used to eliminate existing parasites. Some parasiticides may target specific types of parasites, while others may have a broader spectrum of activity. It is important for pet owners to consult with a veterinarian to determine the most appropriate parasiticide for their pet, as well as the correct dosage and administration schedule. Additionally, pet owners should follow the recommended guidelines for storing and administering parasiticides, as improper use can lead to adverse effects or reduced efficacy.

The companion animal parasiticides market is expected to grow significantly in the coming years, driven by a number of factors. One of the key drivers of growth in the market is the increasing prevalence of parasitic diseases in companion animals. As the number of companion animals continues to grow, so too does the risk of these animals becoming infected with parasites such as fleas, ticks, and worms. This has led to a growing demand for products that can effectively treat and prevent these parasites. In addition to the increasing prevalence of parasitic diseases, there are a number of other factors driving growth in the market. These include the growing awareness among pet owners of the importance of protecting their animals from parasites, the availability of a wide range of products to treat and prevent parasites, and the increasing availability of these products in veterinary clinics and pet stores.

COVID-19 Impact: Market Growth Hampered By Pandemic Due to Disruptions in Supply Chains

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic has had a significant negative impact on the companion animal parasiticides market. The pandemic has led to disruptions in supply chains, reduced demand due to economic uncertainty, and delays in product approvals and registrations. These factors have all contributed to a decrease in revenue and profitability for companies in the market. Additionally, pet owners have been spending less on non-essential products and services, including parasiticides, due to financial constraints and a focus on essential items. This has further impacted sales and revenue for companies in the market. Overall, the COVID-19 pandemic has had a detrimental impact on the market, with reduced demand, disruptions in supply chains, and delays in product approvals and registrations leading to decreased revenue and profitability for companies in the market.

LATEST TRENDS

"Increasing Use of Combination Products to Drive Market Growth"

The companion animal parasiticides market has seen a number of emerging trends in recent years. One of the most significant trends is the increasing use of combination products, which combine multiple active ingredients to provide a broader spectrum of protection against parasites. This trend has been driven by the growing demand for more effective and convenient treatment options, as well as the need to combat the development of resistance to individual active ingredients. Another important trend is the increasing availability of parasiticides in different formulations, such as oral tablets, spot-on treatments, and collars. This has made it easier for pet owners to find a product that suits their pet's specific needs and preferences. The market has also seen a rise in the use of natural and organic products, as pet owners become more concerned about the potential health risks associated with traditional chemical-based products. This trend has been driven by the growing popularity of holistic and natural approaches to pet care, as well as increased consumer awareness of the potential risks associated with chemical-based products.

COMPANION ANIMAL PARASITICIDES MARKET SEGMENTATION

By Type

Based on type the global market can be categorized into Endoparasiticides, Ectoparasiticides, Endectocides.

• Endoparasiticides: These are parasiticides that are used to treat internal parasites, such as intestinal worms, heartworms, and blood parasites. They can come in various forms, including tablets, liquids, or injectables. Common examples include fenbendazole, ivermectin, and pyrantel pamoate.

• Ectoparasiticides: These are parasiticides that are used to treat external parasites, such as fleas, ticks, and mites. They can come in various forms, including spot-on treatments, shampoos, sprays, and collars. Common examples include fipronil, imidacloprid, and permethrin.

• Endectocides: These are parasiticides that are effective against both internal and external parasites. They can come in various forms, including tablets, spot-on treatments, and injectables. Common examples include moxidectin and selamectin.

By Application

Based on application the global market can be categorized into Dogs/Cats, Equine.

• Dogs/Cats: Parasiticides are commonly used in dogs and cats to prevent or treat infestations of external parasites such as fleas, ticks, and mites, as well as internal parasites like heartworms, roundworms, and tapeworms.

• Equine: Parasiticides are also used in horses to control and prevent infestations of external parasites such as ticks, lice, and flies, as well as internal parasites like strongyles, ascarids, and tapeworms.

DRIVING FACTORS

"Increasing Prevalence of Parasitic Infections to Boost the Market Growth"

The companion animal parasiticides market is driven by several key factors that contribute to its growth and expansion. These factors include the increasing prevalence of parasitic infections in companion animals, the growing awareness among pet owners about the importance of parasite prevention and control, and the rising demand for effective and safe parasiticides. One of the primary factors driving the companion animal parasiticides market growth is the increasing prevalence of parasitic infections in companion animals. Parasitic infections, such as fleas, ticks, heartworms, and intestinal worms, are common in pets and can cause a range of health problems, including skin irritation, anemia, and even death in severe cases. As a result, pet owners are increasingly seeking effective solutions to prevent and control these parasites in their pets. Another factor driving the growth of the market is the growing awareness among pet owners about the importance of parasite prevention and control. With the increasing availability of information on the internet and through other sources, pet owners are becoming more educated about the risks of parasitic infections and the importance of regular parasite prevention and control measures. This has led to an increase in demand for effective and safe parasiticides that can protect pets from parasites without causing harm to their health.

"Rising Demand for Effective and Safe Parasiticides to Expand the Market"

The rising demand for effective and safe parasiticides is also driving the growth of the companion animal parasiticides market. As pet owners become more aware of the risks of parasitic infections and the importance of prevention and control measures, they are seeking out products that are both effective and safe for their pets. This has led to a growing demand for parasiticides that are formulated with safe and natural ingredients and that have been rigorously tested for safety and efficacy. In addition to these factors, the market is also being driven by technological advancements and innovations in the field of parasitology. Advances in technology have led to the development of new and improved parasiticides that are more effective at preventing and controlling parasitic infections in companion animals. These technological advancements have also led to the development of new delivery methods for parasiticides, such as spot-on treatments and oral medications, which are more convenient and easier to administer than traditional methods.

RESTRAINING FACTORS

"Regulatory Constraints to Impede Market Growth"

Regulatory constraints can be a major factor restraining the growth of the companion animal parasiticides market. Regulatory bodies like the FDA in the US, EMA in Europe, and other regional regulatory authorities have strict guidelines and approval processes for the registration and sale of parasiticides. Meeting these regulatory requirements can be time-consuming and costly for manufacturers, which can act as a barrier to entry for new players and a restraint on market growth. Developing and manufacturing parasiticides can be expensive due to the need for extensive research and development, clinical trials, and regulatory compliance. This can result in high costs for manufacturers, which can be passed on to consumers, making these products less accessible to some pet owners.

• 

   Request a Free Sample To Get Analysis on Major Geographic Market

COMPANION ANIMAL PARASITICIDES MARKET REGIONAL INSIGHTS

"North America to Dominate in the Market due to Presence of a Large Consumer Base"

The market is segmented into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

North America has emerged as the most dominant region in the global Companion animal parasiticides market share. The region particularly the U.S. and Canada, has a large pet population, and there is a growing awareness among pet owners about the importance of controlling parasites in their pets. Additionally, the presence of major players in the region contributes to the growth of the market. There is also a growing trend of humanization of pets, leading to increased spending on pet care products, including parasiticides.

KEY INDUSTRY PLAYERS

"Key Industry Players Shaping the Market through Innovation and Market Expansion"

The Companion animal parasiticides market is significantly influenced by key industry players that play a pivotal role in driving market dynamics and shaping consumer preferences. These key players possess extensive retail networks and online platforms, providing consumers with easy access to a wide variety of wardrobe options. Their strong global presence and brand recognition have contributed to increased consumer trust and loyalty, driving product adoption. Moreover, these industry giants continually invest in research and development, introducing innovative designs, materials, and smart features in Companion animal parasiticides, catering to evolving consumer needs and preferences. The collective efforts of these major players significantly impact the competitive landscape and future trajectory of the market.

List of Top Companion Animal Parasiticides Companies

• Boehringer Ingelheim (Germany)
• Zoetis (U.S.)
• Merck (U.S.)
• Elanco (U.S.)
• Bayer (Germany)
• Virbac (France)
• Ceva Sante Animale (France)

INDUSTRIAL DEVELOPMENT

April 2022: Veterinarians can now prescribe Felpreva, a novel approach to feline parasite prevention, in the UK, according to a news release from Vetoquinol in April 2022. Following the November 2021 marketing permission granted by the Veterinary Medicines Directorate (VMD), this remark was made.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.